PDS BIOTECHNOLOGY CORP's ticker is and the CUSIP is 70465T957. A total of 3 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $183 | -2.7% | 36,400 | -2.9% | 0.00% | – |
Q2 2023 | $188 | +526.7% | 37,500 | +650.0% | 0.00% | – |
Q1 2023 | $30 | -88.0% | 5,000 | -73.5% | 0.00% | – |
Q4 2022 | $249 | -87.6% | 18,900 | +2262.5% | 0.00% | – |
Q3 2022 | $2,000 | -95.8% | 800 | -94.0% | 0.00% | – |
Q2 2022 | $48,000 | -38.5% | 13,400 | +5.5% | 0.00% | – |
Q1 2022 | $78,000 | +3800.0% | 12,700 | +4133.3% | 0.00% | – |
Q4 2021 | $2,000 | -97.5% | 300 | -95.5% | 0.00% | – |
Q3 2021 | $81,000 | -1.2% | 6,600 | 0.0% | 0.00% | – |
Q2 2021 | $82,000 | – | 6,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 2,000 | $12,300 | 0.00% |
SIMPLEX TRADING, LLC | 5,000 | $30 | 0.00% |